Will Johnson & Johnson Remain A Top Dividend Aristocrat Stock Going Forward? (NYSE:JNJ)

Sealed Bottle of Extra Strength Tylenol Caplets with Box

skhoward/iStock Unreleased via Getty Images

Johnson and Johnson (NYSE:JNJ) has been in the news lately, largely for reasons they prefer not to have. For context, Johnson & Johnson has been served with thousands of potential lawsuits regarding talc issues within their once-popular Johnson’s

ycharts.com

ycharts

ycharts.com

ycharts

dividendhike.com

Dividend Hike

fastgraphs.com

Fast Graphs

Be the first to comment

Leave a Reply

Your email address will not be published.


*